The Huffington Post and AOL
The Huffington Post may not be a bad buy at the price AOL is paying, but that does not mean that AOL is right to buy it. (more…)
Demand Media IPO
I usually comment only on British companies (as investments, that is), but I also like to keep an eye on tech and internet companies, and on anything that illustrates a point. Demand Media falls in to both categories. (more…)
Blog split
I have effectively split this blog into two. I will stop posting on investment and finance related topics here, and instead post on my new blog on my Moneyterms site. (more…)
Comments disabled
Wogen not irrationally priced
Richard Beddard appears to be willing to agree with me that most active investors will under-perform. We still disagree about how investors’ chances of out-performing are. Richard has focused on a particular company , Wogen, as an example of irrational underpricing. Naturally, it is now essential that I poke a few holes in his bullish analysis. (more…)
The end of academic publishing
It has been clear to many analysts (including myself) for years that publishers of academic journals were facing the slow death of their business. Despite the view of publishers and the more optimistic analysts that peer reviews journals were irreplaceable, the evidence continues to emerge for a slow, but certain, decline. (more…)
Will equity returns stay high?
The fascinating information on the drivers of returns on equities between the fifties and the nineties dug up by Richard Beddard, has a worrying aspect. Much of the gain came from one-off changes, so returns may not be as good in the future. (more…)
Emerging markets, inflation and currency risk
A post at Interactive Investor Blog on the nominal good performance of Zimbabwe’s stock exchange, is a useful reminder of the importance of real returns. This works both ways, and is why equity investors should not worry too much about currency risk. (more…)
Comments disabled
Can Woolworths recover?
I have never liked Woolworths, with its weak brand, unfocused retail format, and uncertain wholesale business. Now, at a time when things could not look worse, I am changing my mind. (more…)
Vodafone’s loss that wasn’t
According to most of the press Vodafone made a £15bn loss in the 2005/6 financial year. The largest loss ever made by a British company. In fact, it would be more accurate to say that the company made a real profit but an accounting loss. (more…)
Comments disabled
Skyepharma – problems solved, price still down
Either the market is simply not prepared to be anything but negative on Skyepharma or I am missing something. The problems with Paxil continue, but Skyepharma has been shielded from the effects of this by a new agreement with Glaxosmithkline’s which gives Skyepharma the royalties on the budgeted sales until normal sales resume.
(more…)
Feed